- Associate Professor of Pediatrics, CWRU School of Medicine
- Clinical Assistant Professor of Genetics, CWRU School of Medicine
- Associate Professor of Genetics, CWRU School of Medicine
Suzanne D. DeBrosse, M.D. is a clinical geneticist in the Center for Human Genetics at University Hospitals Cleveland Medical Center since 2011 and an Associate Professor of Genetics and Genome Sciences, Pediatrics Neurology at Case Western Reserve University.
Dr. DeBrosse's clinical interest includes genetics focusing on diseases of the nervous system in both children and adults. Her research focuses on neurological outcomes in pyruvate dehydrogenase complex (PDC) deficiency, an inborn error of metabolism.
She is a member of the Alternating Hemiplegia of Childhood (AHC) Foundation's medical advisory board and is interested in ATP1A3-related disorders, including AHC. In 2018, she was named a senior attending physician as part of the Distinguished Physician Program's inaugural class at University Hospitals Cleveland Medical Center.
Dr. DeBrosse is a graduate of Case Western Reserve University School of Medicine and completed residencies in Pediatrics, Child Neurology, and Medical Genetics at Rainbow Babies & Children's Hospital and University Hospitals Cleveland Medical Center. She is board certified in Pediatrics, Neurology with Special Qualification in Child Neurology, and Medical Genetics.
Research & Publications
Certifications & Memberships
- Clinical Genetics and Genomics - American Board of Medical Genetics and Genomics
- Pediatrics - American Board of Pediatrics
- Neurology with Special Qualifications in Child Neurology - American Board of Psychiatry and Neurology
Residency | Medical Genetics
Medical Genetics - Uh Case Medical Center (2009 - 2011)
Residency | Child Neurology
Child Neurology - Uh Case Medical Center (2006 - 2009)
Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (2004 - 2006)
Case Western Reserve University School Of Medicine (2004)
Case Western Reserve University (2000)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Suzanne DeBrosse did not disclose any Outside Relationships with Industry.